Activity

A New Drug, Developed At John Hopkins, Could Be The First To Slow The Progression Of Parkinson’s Disease. The Drug, NLY01, Similar To A Group Of Drugs Used In Managing Type 2 Diabetes, Was Found To Be Effective In Stopping The Disease Progression In Mice. Hoping For The Best In Human Trials!

Phase 2 Parkinson's Trial of NLY01 in Protecting Neurons Fully Enrolled

https://parkinsonsnewstoday.com/2022/04/26/phase-2-trial-of-nly01-in-slowing-disease-progression-fully-enrolled/

Neuraly announced 255 early-stage patients were testing NLY01 and its ability to slow or stop motor progression; results due by mid-2023.